Miguel Ramalho

Dr. Miguel Ramalho

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2015 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JRJ. Ramalho
J. Ramalho
RSRichard C. Semelka
Richard C. Semelka
MRMiguel Ramalho
Miguel Ramalho
RNR. H. Nunes
R. H. Nunes
MAM. AlObaidy
M. AlObaidy
MCM. Castillo
M. Castillo
SUMMARY: In current practice, gadolinium-based contrast agents have been considered safe when used at clinically recommended doses in patients without severe renal insufficiency. The causal relationship between gadolinium-based contrast agents and nephrogenic systemic fibrosis in patients with renal insufficiency resulted in new policies regarding the administration of these agents. After an effective screening of patients with renal disease by performing either unenhanced or reduced-dose-enhanced studies in these patients and by using the most stable contrast agents, nephrogenic systemic fibrosis has been largely eliminated since 2009. Evidence of in vivo gadolinium deposition in bone tissue in patients with normal renal function is well-established, but recent literature showing that gadolinium might also deposit in the brain in patients with intact blood-brain barriers caught many individuals in the imaging community by surprise. The purpose of this review was to summarize the literature on gadolinium-based contrast agents, tying together information on agent stability and animal and human studies, and to emphasize that low-stability agents are the ones most often associated with brain deposition.

1 September 2015 in Radiology
Verified
Journal Article
Closed access
JRJoana Ramalho
Joana Ramalho
MCMauricio Castillo
Mauricio Castillo
MAMamdoh AlObaidy
Mamdoh AlObaidy
RNRenato H. Nunes
Renato H. Nunes
MRMiguel Ramalho
Miguel Ramalho
RSRichard C. Semelka
Richard C. Semelka
To determine if a correlation exists between the number of previous enhanced magnetic resonance (MR) imaging examinations and high signal intensity in the globus pallidus (GP) and dentate nucleus (DN) in patients who received gadodiamide (Omniscan), a linear nonionic gadolinium-based contrast agent, and in those who received gadobenate dimeglumine (MultiHance), a linear ionic contrast agent. Institutional review board approval was obtained for this single-center retrospective study, with waiver of informed consent. The study population included 69 patients divided into two groups: Group 1 included patients who underwent gadodiamide-enhanced MR imaging, and group 2 included patients who underwent gadobenate dimeglumine-enhanced MR imaging. Two radiologists conducted a quantitative analysis of unenhanced T1-weighted images by using region of interest measurements. The GP-to-thalamus (TH) signal intensity ratio, DN-to-middle cerebellar peduncle (MCP) signal intensity ratio and relative percentage change (Rchange) between the first and last examinations for each patient were calculated. Relation between the signal intensity ratios and Rchange and the number of enhanced MR imaging examinations was analyzed by using a generalized additive model. Inter- and intraobserver agreement was evaluated with the Lin concordance correlation coefficient test. Group 1 included 23 patients (19 female), with a mean of 5.0 doses ± 2.4 (standard deviation) (range, 3-11 doses) administered. Group 2 included 46 patients (24 female) with a mean of 4.6 doses ± 2.2 (range, 3-11 doses) administered. The interval between the first and last examination was 1500.1 days ± 780.2 (range, 98-3097 days) for group 1 and 1086.2 days ± 582.9 (range, 94-2633) for group 2. All patients had normal liver and renal function. Gadodiamide showed a significant increase in DN:MCP and GP:TH (P < .001 for both) and in Rchange (P = .001 for GP:TH, P < .001 for DN:MCP). In group 2, there was no significant increase in DN:MCP or GP:TH over time or in Rchange for GP:TH, but there was a significant trend toward an increase in Rchange for DN:MCP (P = .013). Interobserver agreement was almost perfect (0.99; 95% confidence interval: 0.99, 0.99) for all evaluated structures. Intraobserver agreement was substantial to almost perfect for both readers. A significant increase in GP:TH and DN:MCP is associated with multiple gadodiamide-enhanced studies but not with gadobenate dimeglumine-enhanced studies, likely reflecting differences in stability and elimination of both contrast agents. Rate-of-change data indirectly suggest gadolinium deposition in the DN with gadobenate dimeglumine use, although it is considerably less than that with gadodiamide use.

1 December 2016 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
RSRichard C. Semelka
Richard C. Semelka
JRJoana Ramalho
Joana Ramalho
AVAmi Vakharia
Ami Vakharia
MAMamdoh AlObaidy
Mamdoh AlObaidy
LBLauren M. Burke
Lauren M. Burke
MRMiguel Ramalho
Miguel Ramalho

1 December 2016 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
JRJoana Ramalho
Joana Ramalho
MRMiguel Ramalho
Miguel Ramalho
MJMichael Jay
Michael Jay
LBLauren M. Burke
Lauren M. Burke
RSRichard C. Semelka
Richard C. Semelka

1 January 2014 in World Journal of Gastrointestinal Pathophysiology
Verified
Journal Article
Open access
KBKiran K Busireddy
Kiran K Busireddy
MAMamdoh AlObaidy
Mamdoh AlObaidy
MRMiguel Ramalho
Miguel Ramalho
JKJanaka Kalubowila
Janaka Kalubowila
LBLiu Baodong
Liu Baodong
RSRichard C. Semelka
Richard C. Semelka
Pancreatitis is defined as the inflammation of the pancreas and considered the most common pancreatic disease in children and adults. Imaging plays a significant role in the diagnosis, severity assessment, recognition of complications and guiding therapeutic interventions. In the setting of pancreatitis, wider availability and good image quality make multi-detector contrast-enhanced computed tomography (MD-CECT) the most used imaging technique. However, magnetic resonance imaging (MRI) offers diagnostic capabilities similar to those of CT, with additional intrinsic advantages including lack of ionizing radiation and exquisite soft tissue characterization. This article reviews the proposed definitions of revised Atlanta classification for acute pancreatitis, illustrates a wide range of morphologic pancreatic parenchymal and associated peripancreatic changes for different types of acute pancreatitis. It also describes the spectrum of early and late chronic pancreatitis imaging findings and illustrates some of the less common types of chronic pancreatitis, with special emphasis on the role of CT and MRI.

1 May 2017 in Advances in Chronic Kidney Disease
Verified
Journal Article
Closed access
PDF file
MRMiguel Ramalho
Miguel Ramalho
JRJoana Ramalho
Joana Ramalho
LBLauren M. Burke
Lauren M. Burke
RSRichard C. Semelka
Richard C. Semelka